MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$20,156K
Net Income
-$46,954K
Net Profit Margin
-232.95%
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
20,156
19,474
53,644*
38,837
Cost of revenue-Service
-
-
7,880*
-
Cost of biosecurity revenue-Biosecurity
-
-
-
8,177
Cost of revenue-Product
-
-
0*
-
Cost of biosecurity revenue-Other Revenue
-
-
-
4,625
Cost of revenue-Product And Service Other
-
-
3,863*
-
Cost of other revenue
1,719
3,098
-
-
Research and development
46,210
49,920
35,714*
69,353
General and administrative
30,775
37,830
43,537*
44,954
Impairment of lease assets
-
-
0*
-
Goodwill impairment
-
-
0*
0
Restructuring charges
0
0
6,163*
1,745
Total operating expenses
78,704
90,848
97,157*
128,854
Loss from operations
-58,548
-71,374
-43,513*
-90,017
Interest income
-
-
5,654*
-
Interest expense
-
-
0*
-
Interest income, net
3,232
3,596
-
5,742
Loss on equity method investment
-4,673
-
0*
-
Gain (loss) on investments
1,987
-1,214
-27,727*
3,684
Loss on deconsolidation of subsidiary
-
-
-
0
Loss on deconsolidation of subsidiaries
-
-
0*
-
Change in fair value of warrant liabilities
-
-
0*
0
Other income (expense), net
809
-7,147
-4,038*
-163
Total other income (expense)
1,355
-4,765
-26,111*
9,263
Loss from continuing operations before income taxes
-57,193
-76,139
-69,624*
-80,754
Income tax (benefit) expense
128
-80
-840*
1
Net loss from continuing operations
-57,321
-76,059
-
-
Net income (loss) from discontinued operations, net of tax
10,611
-6,528
-
-
Net loss
-46,710
-82,587
-68,784*
-80,755
Foreign currency translation adjustment
-34
-579
883*
27
Reclassification of foreign currency translation adjustment realized upon sale of foreign subsidiary
-
-
0*
0
Unrealized gain on available-for-sale securities
-
-
-31*
-
Unrealized (loss) gain on available-for-sale securities
-210
-78
-
316
Total other comprehensive income (loss)
-
-
914*
-
Total other comprehensive (loss) income
-244
-657
-
343
Comprehensive loss
-46,954
-83,244
-67,870
-80,412
Basic EPS
-0.75
-1.39
-1.228
-1.45
Diluted EPS
-
-
-1.228
-1.45
Basic Average Shares
62,094,356
59,563,454
55,281,634
55,633,718
Diluted Average Shares
-
-
55,281,634
55,633,718
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$46,954K
Net loss
-$46,710K
Total other
comprehensive (loss) income
-$244K
Net income (loss)
from discontinued...
$10,611K
Net loss from
continuing operations
-$57,321K
Unrealized (loss) gain on
available-for-sale securities
-$210K
Foreign currency
translation adjustment
-$34K
Interest income, net
$3,232K
Gain (loss) on
investments
$1,987K
Other income
(expense), net
$809K
Loss from continuing
operations before income...
-$57,193K
Income tax (benefit)
expense
$128K
Total other income
(expense)
$1,355K
Loss on equity method
investment
-$4,673K
Loss from operations
-$58,548K
Revenue
$20,156K
Total operating
expenses
$78,704K
Research and development
$46,210K
General and
administrative
$30,775K
Cost of other revenue
$1,719K
Buy us a coffee
Ginkgo Bioworks Holdings, Inc. (DNABW)
Ginkgo Bioworks Holdings, Inc. (DNABW)